Back to search

Boston University

Insights into immune checkpoint-related pneumonitis: a case series from Massachusetts General Hospital

Abstract

dc:description.abstract

While checkpoint inhibitor immunotherapy has afforded patients with cancer a new and effective treatment option, it also comes with potentially fatal side effects such checkpoint-induced pneumonitis. Due the relatively rare and severe nature of this adverse event, mechanisms of pneumonitis are poorly understood. Therefore, research needs to be focused on how we can better risk stratify and predict outcomes for patients receiving checkpoint inhibitors. This case series focuses on patients with checkpoint induced pneumonitis and their outcomes in the context of pulmonary co-morbidities. We found that patients with pre-existing pulmonary conditioned had a faster and more severe outcomes than their counterparts. This further underscores the importance of understandings risk factors, treatment options and early monitoring for these patients.

Degree

thesis:*
Name thesis:degree_name
Master of Science
Level thesis:degree_level
masters
Discipline thesis:degree_discipline
Medical Sciences
Grantor
Boston University
Year dc:date.issued
2025

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Kalaria, Ceanna
Advisors dc:contributor.advisor
  • Tornheim, Keith
  • Hallowell, Robert

Subjects

dc:subject × 3

Rights

Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/2144/52306

Chain of custody

source
Harvested from
Boston University
Base URL
open.bu.edu/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Kalaria, Ceanna. Insights into immune checkpoint-related pneumonitis: a case series from Massachusetts General Hospital. masters thesis, Boston University, 2025. https://hdl.handle.net/2144/52306